Buy or sell TriNetX stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

TriNetX Stock

Global health research network

Founded

2013

Headquarters

Cambridge MA, US

Total Funding

$42.5M

About TriNetX Stock

TriNetX is the global health research network enabling healthcare organizations, biopharmaceutical companies and contract research organizations (CROs) to collaborate, enhance trial design, improve site selection and planning, and bring new therapies to market faster. TriNetX combines real time access to longitudinal clinical data with analytics to answer complex research questions. The TriNetX platform is HIPAA and GDPR compliant.

Funding History

February 2016$2.5M
March 2019$40.0M

Management

Chief Commercial Officer

Brian Flaherty

Senior Vice President, Marketing

Jennifer Haas

Chief Medical Officer

Manfred Stapff

Chief Technology Officer

Steve Kundrot

Senior Vice President, Finance & Administration

Chris Fraser

Senior Vice President, Corporate Development

Maulik Mehta

Senior Vice President, Global Data Networks

Steve Lethbridge

Chief Executive Officer

Gadi Lachman

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from TriNetX or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo